Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Mi

Showing results (101-110 of 1,447) with videos related to

Pageof 145
Sort By:
Pediatrics International : Official Journal of the Japan Pediatric Society|November 1, 2012
Factors affecting exclusive breast-feeding during the first 6 months in KoreaMyo Jing Kim, Yu-Mi Kim, Jae-Ho Yoo
Journal of Oral Biosciences|June 22, 2024
Botulinum toxin type A is a potential therapeutic drug for chronic orofacial painYu-Mi Kim, Jo-Young Son, Dong-Kuk Ahn
Cardiology|September 24, 2024
Improved Outcomes following a Conservative Approach to Hemodynamically Significant Patent Ductus Arteriosus: A Comparison across Two PeriodsYu-Mi Seo, Sae Yun Kim, Young-Ah Youn
European Journal of Nutrition|March 15, 2003
A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus--a randomized controlled trial under free-living conditionsYu-Mi Lee, Burkhard Haastert, Werner Scherbaum, et al.
International Journal of Pharmaceutics|October 18, 2011
Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agentsYutao Liu, Yu Mi, Jing Zhao, et al.
Biomaterials|December 14, 2011
Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blendJing Zhao, Yu Mi, Yutao Liu, et al.
Radiation Research|August 24, 2010
Life span and thymic lymphoma incidence in high- and low-dose-rate irradiated AKR/J mice and commonly expressed genesSuk Chul Shin, Yu Mi Kang, Hee Sun Kim
Nanomedicine (London, England)|March 10, 2011
Herceptin®-conjugated nanocarriers for targeted imaging and treatment of HER2-positive cancerYu Mi, Yutao Liu, Yajun Guo, et al.
Vaccines|August 28, 2021
Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare WorkersYu-Mi Wi, Si-Ho Kim, Kyong-Ran Peck
Advances in Experimental Medicine and Biology|October 13, 2016
Validation of Effective Therapeutic Targets for ADPKD Using Animal ModelsYu Mi Woo, Je Yeong Ko, Eun Ji Lee
Pageof 145

Showing results (101-110 of 1,447) with videos related to

Sort By:
Pageof 145
Pediatrics International : Official Journal of the Japan Pediatric Society|November 1, 2012
Factors affecting exclusive breast-feeding during the first 6 months in KoreaMyo Jing Kim, Yu-Mi Kim, Jae-Ho Yoo
Journal of Oral Biosciences|June 22, 2024
Botulinum toxin type A is a potential therapeutic drug for chronic orofacial painYu-Mi Kim, Jo-Young Son, Dong-Kuk Ahn
Cardiology|September 24, 2024
Improved Outcomes following a Conservative Approach to Hemodynamically Significant Patent Ductus Arteriosus: A Comparison across Two PeriodsYu-Mi Seo, Sae Yun Kim, Young-Ah Youn
European Journal of Nutrition|March 15, 2003
A phytosterol-enriched spread improves the lipid profile of subjects with type 2 diabetes mellitus--a randomized controlled trial under free-living conditionsYu-Mi Lee, Burkhard Haastert, Werner Scherbaum, et al.
International Journal of Pharmaceutics|October 18, 2011
Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agentsYutao Liu, Yu Mi, Jing Zhao, et al.
Biomaterials|December 14, 2011
Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blendJing Zhao, Yu Mi, Yutao Liu, et al.
Radiation Research|August 24, 2010
Life span and thymic lymphoma incidence in high- and low-dose-rate irradiated AKR/J mice and commonly expressed genesSuk Chul Shin, Yu Mi Kang, Hee Sun Kim
Nanomedicine (London, England)|March 10, 2011
Herceptin®-conjugated nanocarriers for targeted imaging and treatment of HER2-positive cancerYu Mi, Yutao Liu, Yajun Guo, et al.
Vaccines|August 28, 2021
Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare WorkersYu-Mi Wi, Si-Ho Kim, Kyong-Ran Peck
Advances in Experimental Medicine and Biology|October 13, 2016
Validation of Effective Therapeutic Targets for ADPKD Using Animal ModelsYu Mi Woo, Je Yeong Ko, Eun Ji Lee
Pageof 145